Economic Atlas
Companies/Senti Biosciences, Inc.
Company profile

Senti Biosciences, Inc.

NASDAQ: SNTI · Healthcare · Biotechnology
PublicHQ South San Francisco, CA · San MateoCIK 0001854270Reports USD
#1115 of 1,422 Healthcare companies by revenue
EA Score
27D
Revenue TTM
$38.0k
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$61.4M
Employees
39
as of 2026-08-20
Market cap
$14.4M
as of 2026-08-20

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$22.0k$22.0k2025
Net income-$61.4M-$61.4M2025
Operating income-$68.8M-$68.8M2025
Total assets$51.2M$51.2M2025
Liabilities$45.6M$45.6M2025
Equity$5.6M$5.6M2025

Revenue trend

FY2022 – FY2025 · USD
FY22
FY22
FY23
FY24
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Reportable100%
By geography

Not disclosed.

The read

What is Senti Biosciences, Inc.’s revenue?

Senti Biosciences, Inc. booked $22.0k in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -279263.6% net margin.

Peers · Healthcare
Proteonomix, Inc.——Sirona Biochem Corp.——Doseology Sciences Inc.40DJupiter Neurosciences, Inc.18DSkinvisible, Inc.29DSouth American Gold Corp.——
Neighbors
San Mateo →
Meta Platforms, Inc.$201.0B86AGilead Sciences, Inc.$29.4B87AEquinix, Inc.$9.2B74BRobinhood Markets, Inc.$4.5B67BElectronic Arts Inc.$7.5B82B+Revolution Medicines, Inc.$052D
Key facts
CEOTimothy K. Lu
SectorHealthcare
IndustryBiotechnology
HeadquartersSouth San Francisco, CA
ExchangeNASDAQ: SNTI
Employees39
IPO date2021-05-26
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.